Ganirelix

• Target:

  GNRH Receptor

• Related Pathways:

  GPCR/G Protein

• Bioactivity:

  Ganirelix is a selective and competitive antagonist of gonadotropin-releasing hormone (GnRH), effectively inhibiting endogenous GnRH from inducing the release of luteinizing hormone (LH) and follicle-stimulating hormone [1].

• Smiles:

  C ([C@@H] (NC ([C@@H] (NC ([C@H] (NC ([C@H] (CC1=CC=C (O) C=C1) NC ([C@@H] (NC ([C@H] (NC ([C@@H] (CC2=CC=C (Cl) C=C2) NC ([C@@H] (CC3=CC4=C (C=C3) C=CC=C4) NC (C) =O) =O) =O) CC=5C=CC=NC5) =O) CO) =O) =O) CCCCN=C (NCC) NCC) =O) CC (C) C) =O) CCCCN=C (NCC) NCC) (=O) N6[C@H] (C (N[C@@H] (C (N) =O) C) =O) CCC6

• Molecular Formula:

  C80H113ClN18O13

• Molecular Weight:

  1570.32

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  124904-93-4